- What is the purpose of the study – is it to determine a new drug or suggest a new combination of drugs/treatment?
- Who has reviewed and approved the study?
- How are study results and safety of participants being checked?
- What kinds of therapies, procedures and/or tests will I have during the trial?
- How will the trial affect my current treatment plan and affect my daily life?
- Will I be taken off my current treatment or will I continue to take my regular medications while in the trial?
- Where will I have my medical care, and who will be in charge of my care?
- If the person in charge of my medical care during the trial is different from my current doctor, what will be the communication/interaction between the two?
- What are the benefits to my treatment and my health connected with this trial?
- What are the potential short-term and long term risks connected with this trial?
- Can I talk to other people in the study?
- What is the procedure for quitting the study once I have started it?
- Will there be costs to me if I participate?
- Will my insurance cover the costs?
- What are my responsibilities if I participate?
- How long will I be in the study?
Community outreach played an important role in the 2018 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer, held March 24-27 in New Orleans.
September is Gynecologic Cancer Awareness Month. After creating the month in 1999, the Foundation strives to bring attention about these cancers through public awareness campaigns.